Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Go long in Jain Irrigation, says Sudarshan Sukhani of s2analytics.com.
In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi of Peerless Securities shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Sun Pharmaceuticals and Lupin are top picks, says Mehraboon Irani, Nirmal Bang Securities.
Buy ACC and Sun Pharma, says Sudarshan Sukhani of s2analytics.com. Sun Pharma has again edged out of a trading range. It is on the verge of making lifetime new highs. It hasn‘t done that but perhaps it will do it today or in the next few days, he adds.
In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi of sharmilajoshi.com shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
As the market enters into another volatile week, here are some of cherry picked stocks by SP Tulsian of sptulsian.com.
On CNBC-TV18's show Super Six, market gurus Manav Chopra of Nirmal Bang, Rajesh Jain of Religare Sec and Rakesh Gandhi of FRR shares, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Ambareesh Baliga, Market Expert advice traders to buy SBI around Rs 2060.
Dishman Pharmaceuticals & Chemicals has target of Rs 145-150, says Ambareesh Baliga, Independent Analyst.
SP Tulsian of sptulsian.com is not very satisfied with the performance of the aluminium segment of Hindalco. According to him, its copper division has done better and the overall performance of NALCO, Sterlite and the consolidated operations of BALCO has been poor, resulting in a poor aluminium segment performance.
Shasun Pharma may cross Rs 200-210, says Ambareesh Baliga, Market Analyst.
In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
In CNBC-TV18's popular show Bull's Eye, Pankaj Jain, Sunteck Wealthmax shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Anu Jain of IIFL Private Wealth Management advice traders to hold Ranbaxy Labs with stop loss of Rs 540.
In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.
Dishman Pharma can move to Rs 135- 140, says Ambareesh Baliga, COO, Way2Wealth.
In CNBC-TV18's popular show Bull's Eye, Aashish Tater, Fort Share Broking shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.